Advertisement
Screener

COMPASS THERAPEUTICS, INC. (CMPX) Lessee, Operating Lease, Liability, to be Paid, Year Three

2.8 / 5 stars · 68/120 Roast Me

COMPASS THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year Three

COMPASS THERAPEUTICS, INC. (CMPX) had Lessee, Operating Lease, Liability, to be Paid, Year Three of $2.29 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2026-08-06

  • 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.29M.
  • 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.29M.
  • 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.25M.
  • 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $2.25M.
Period endLessee, Operating Lease, Liability, to be Paid, Year Three
2026-06-30$2.29M
10-Q · filed 2026-08-06
2026-03-31$2.29M
10-Q · filed 2026-05-05
2025-09-30$2.25M
10-K · filed 2026-03-05
2025-06-30$2.25M
10-Q · filed 2025-08-11
2025-03-31$1.44M
10-Q · filed 2025-05-08
2024-12-31$1.41M
10-K · filed 2025-02-27
2024-09-30$1.41M
10-Q · filed 2024-11-12
2022-12-31$543.00K
10-K · filed 2023-03-15
2022-09-30$543.00K
10-Q · filed 2022-11-09
2022-06-30$543.00K
10-Q · filed 2022-08-01
2022-03-31$543.00K
10-Q · filed 2022-05-09
2021-12-31$1.38M
10-K · filed 2022-03-18
2021-09-30$1.38M
10-Q · filed 2021-11-12
2021-06-30$1.38M
10-Q · filed 2021-08-16
2021-03-31$1.38M
10-Q · filed 2021-04-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alector, Inc. (ALEC)United States$0.213B-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35